UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Fulton Breakefield Broenniman LLC

Fulton Breakefield Broenniman LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,217 shares of the healthcare conglomerate’s stock after selling 2,170 shares during the period. UnitedHealth Group comprises about 2.5% of Fulton Breakefield Broenniman LLC’s holdings, making the stock its 12th largest position. Fulton Breakefield Broenniman LLC’s holdings in UnitedHealth Group were worth $35,208,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Delta Financial Group Inc. raised its holdings in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after buying an additional 17 shares during the last quarter. Signature Resources Capital Management LLC boosted its position in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the period. Saxony Capital Management LLC increased its holdings in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares during the period. GoalVest Advisory LLC grew its position in UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC raised its position in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. Robert W. Baird lifted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. UBS Group decreased their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Morgan Stanley decreased their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $615.16.

UnitedHealth Group Trading Up 2.7 %

Shares of UnitedHealth Group stock opened at $571.30 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a market cap of $527.55 billion, a price-to-earnings ratio of 37.88, a PEG ratio of 1.69 and a beta of 0.58. The company’s fifty day simple moving average is $584.21 and its 200-day simple moving average is $532.84. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.68 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is 55.70%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.